Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 335

1.

Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern".

Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, Deschepper E, Foeldvari I, Gutierrez M, Hachulla E, Ingegnoli F, Kubo S, Müller-Ladner U, Riccieri V, Sulli A, van Laar JM, Vonk MC, Walker UA, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2019 Sep 11:102394. doi: 10.1016/j.autrev.2019.102394. [Epub ahead of print] Review.

PMID:
31520797
2.

Systemic sclerosis.

Hughes M, Herrick AL.

Br J Hosp Med (Lond). 2019 Sep 2;80(9):530-536. doi: 10.12968/hmed.2019.80.9.530.

PMID:
31498665
3.

RNASEH2B Related Adult-Onset Interferonopathy.

Briggs TA, Paul A, Rice G, Herrick AL.

J Clin Immunol. 2019 Aug;39(6):620-622. doi: 10.1007/s10875-019-00673-w. Epub 2019 Jul 31. No abstract available.

PMID:
31367981
4.

Further evidence that calcinosis is associated with repetitive trauma in systemic sclerosis.

Hughes M, Hodgson R, Harris J, Porter N, Jackson S, Kirwadi A, Manning J, Peytrignet S, Herrick AL.

Semin Arthritis Rheum. 2019 Jul 8. pii: S0049-0172(19)30467-6. doi: 10.1016/j.semarthrit.2019.07.001. [Epub ahead of print] No abstract available.

PMID:
31353058
5.

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles.

Reynolds JA, Briggs TA, Rice GI, Darmalinggam S, Bondet V, Bruce E, Khan M, Haque S, Chinoy H, Herrick AL, McCarthy EM, Zeef L, Hayes A, Duffy D, Parker B, Bruce IN.

Arthritis Res Ther. 2019 Jun 14;21(1):147. doi: 10.1186/s13075-019-1929-4.

6.

Preclinical evaluation of safety and potential of black hellebore extracts for cancer treatment.

Felenda JE, Turek C, Mörbt N, Herrick A, Müller MB, Stintzing FC.

BMC Complement Altern Med. 2019 May 21;19(1):105. doi: 10.1186/s12906-019-2517-5.

7.

Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training.

Snow MH, Saketkoo LA, Frech TM, Stever JR, Lebedoff N, Herrick AL, Cutolo M, Smith V.

Clin Exp Rheumatol. 2019 Apr 5. [Epub ahead of print] No abstract available.

PMID:
31025929
8.

Imaging calcinosis in patients with systemic sclerosis by radiography, computerised tomography and magnetic resonance imaging.

Hughes M, Hodgson R, Harris J, Porter N, Jackson S, Kirwadi A, Manning J, Peytrignet S, Herrick AL.

Semin Arthritis Rheum. 2019 Oct;49(2):279-282. doi: 10.1016/j.semarthrit.2019.03.001. Epub 2019 Mar 9.

PMID:
30981516
9.

Association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis-related calcinosis.

Duffus K, López-Isac E, Teruel M, Simeón CP, Carreria P, Ortego-Centeno N, Vicente E, Worthington J, Herrick AL, Martin J.

Rheumatology (Oxford). 2019 Jul 1;58(7):1299-1301. doi: 10.1093/rheumatology/kez015. No abstract available.

PMID:
30789234
10.

Do thermographic parameters help to classify patients with early systemic sclerosis?

Kelly A, Dinsdale G, Manning J, Herrick AL.

Rheumatology (Oxford). 2019 Jun 1;58(6):1105-1106. doi: 10.1093/rheumatology/kez018. No abstract available.

PMID:
30783679
11.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

12.

Cardiac biomarkers of disordered eating: A case for decreased mean R wave amplitude.

Green M, Herrick A, Kroska E, Reyes S, Sage E, Miles L.

Psychiatry Res. 2019 Feb;272:555-561. doi: 10.1016/j.psychres.2018.12.162. Epub 2018 Dec 30.

PMID:
30616123
13.

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.

González-Serna D, Carmona EG, Ortego-Centeno N, Simeón CP, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F; European GCA Consortium; European Scleroderma Group, Witte T, Neumann T, Holle J, Beretta L, Boiardi L, Emmi G, Cimmino MA, Vaglio A, Herrick AL, Denton CP, Salvarani C, Cid MC, Morgan AW, Fonseca C, González-Gay MA, Martín J, Márquez A.

PLoS One. 2018 Dec 26;13(12):e0209343. doi: 10.1371/journal.pone.0209343. eCollection 2018.

14.

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

Parker MJS, Oldroyd A, Roberts ME, Lilleker JB, Betteridge ZE, McHugh NJ, Herrick AL, Cooper RG, Chinoy H.

Rheumatology (Oxford). 2019 Mar 1;58(3):468-475. doi: 10.1093/rheumatology/key343.

15.

Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study.

Peytrignet S, Manning J, Wragg E, Moore T, Samaranayaka M, Dinsdale G, Herrick AL.

Scand J Rheumatol. 2019 May;48(3):230-234. doi: 10.1080/03009742.2018.1523455. Epub 2018 Nov 5.

PMID:
30394164
16.

A randomised controlled trial of wax baths as an additive therapy to hand exercises in patients with systemic sclerosis.

Gregory WJ, Wilkinson J, Herrick AL.

Physiotherapy. 2019 Sep;105(3):370-377. doi: 10.1016/j.physio.2018.08.008. Epub 2018 Sep 5.

PMID:
30318128
17.

Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?

Dinsdale G, Roberts C, Moore T, Manning J, Berks M, Allen J, Anderson ME, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2019 Feb 1;58(2):284-288. doi: 10.1093/rheumatology/key293.

PMID:
30247696
18.

A preliminary trial of an online dissonance-based eating disorder intervention.

Green MA, Kroska A, Herrick A, Bryant B, Sage E, Miles L, Ravet M, Powers M, Whitegoat W, Linkhart R, King B.

Eat Behav. 2018 Dec;31:88-98. doi: 10.1016/j.eatbeh.2018.08.007. Epub 2018 Sep 4.

PMID:
30199771
19.

Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design.

Hughes M, Tracey A, Bhushan M, Chakravarty K, Denton CP, Dubey S, Guiducci S, Muir L, Ong V, Parker L, Pauling JD, Prabu A, Rogers C, Roberts C, Herrick AL.

J Scleroderma Relat Disord. 2018 Jun 1;3(2):170-174. doi: 10.1177/2397198318764796. Epub 2018 Mar 27.

20.

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.

Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD; SPIN Investigators.

Rheumatology (Oxford). 2018 Sep 1;57(9):1623-1631. doi: 10.1093/rheumatology/key139.

PMID:
29868924
21.

A feasibility study of a novel low-level light therapy for digital ulcers in systemic sclerosis.

Hughes M, Moore T, Manning J, Wilkinson J, Watson S, Samraj P, Dinsdale G, Roberts C, Rhodes LE, Herrick AL, Murray A.

J Dermatolog Treat. 2019 May;30(3):251-257. doi: 10.1080/09546634.2018.1484875. Epub 2018 Jul 31.

22.

Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?

Hughes M, Murray A, Denton CP, Herrick AL.

Med Hypotheses. 2018 Jul;116:101-104. doi: 10.1016/j.mehy.2018.04.024. Epub 2018 May 2.

PMID:
29857890
23.

A Community Engagement Method to Design Patient Engagement Materials for Cardiovascular Health.

English AF, Dickinson LM, Zittleman L, Nease DE Jr, Herrick A, Westfall JM, Simpson MJ, Fernald DH, Rhyne RL, Dickinson WP.

Ann Fam Med. 2018 Apr;16(Suppl 1):S58-S64. doi: 10.1370/afm.2173.

24.

Automated structure and flow measurement - a promising tool in nailfold capillaroscopy.

Berks M, Dinsdale G, Murray A, Moore T, Manning J, Taylor C, Herrick AL.

Microvasc Res. 2018 Jul;118:173-177. doi: 10.1016/j.mvr.2018.03.016. Epub 2018 Mar 29.

25.

The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon.

Herrick AL, Murray A.

Autoimmun Rev. 2018 May;17(5):465-472. doi: 10.1016/j.autrev.2017.11.036. Epub 2018 Mar 9. Review.

PMID:
29526628
26.

Reply.

Denton CP, Herrick AL.

Arthritis Rheumatol. 2018 Jun;70(6):974. doi: 10.1002/art.40480. Epub 2018 May 2. No abstract available.

27.

Longitudinal nailfold capillaroscopy tracking of microangiopathic changes in systemic sclerosis.

Dinsdale G, van Roon AM, Murray A, Taylor C, Herrick AL.

Rheumatology (Oxford). 2018 Sep 1;57(9):1554. doi: 10.1093/rheumatology/key029. No abstract available.

PMID:
29506240
28.

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1373-1384. doi: 10.1002/acr.23475. Epub 2018 Aug 16.

29.

A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.

Wilkinson JD, Leggett SA, Marjanovic EJ, Moore TL, Allen J, Anderson ME, Britton J, Buch MH, Del Galdo F, Denton CP, Dinsdale G, Griffiths B, Hall F, Howell K, MacDonald A, McHugh NJ, Manning JB, Pauling JD, Roberts C, Shipley JA, Herrick AL, Murray AK.

Arthritis Rheumatol. 2018 Jun;70(6):903-911. doi: 10.1002/art.40457. Epub 2018 Apr 23.

30.

The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy.

Dinsdale G, Peytrignet S, Moore T, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2018 Jun 1;57(6):1115-1116. doi: 10.1093/rheumatology/key018. No abstract available.

PMID:
29447411
31.

Tracking digital ulcers in systemic sclerosis: a feasibility study assessing lesion area in patient-recorded smartphone photographs.

Dinsdale G, Moore TL, Manning JB, Murray AK, Atkinson R, Ousey K, Dickinson MR, Taylor C, Herrick AL.

Ann Rheum Dis. 2018 Sep;77(9):1382-1384. doi: 10.1136/annrheumdis-2017-212829. Epub 2018 Feb 3. No abstract available.

PMID:
29431120
32.

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases.

Cutolo M, Melsens K, Herrick AL, Foeldvari I, Deschepper E, De Keyser F, Distler O, Ingegnoli F, Mostmans Y, Müller-Ladner U, Pizzorni C, Riccieri V, Ruaro B, Sulli A, Trombetta AC, Vanhaecke A, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Rheumatology (Oxford). 2018 Apr 1;57(4):757-759. doi: 10.1093/rheumatology/kex460. Review. No abstract available.

33.

Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic Sclerosis.

Dritsoula A, Papaioannou I, Guerra SG, Fonseca C, Martin J, Herrick AL, Abraham DJ, Denton CP, Ponticos M.

Arthritis Rheumatol. 2018 Jun;70(6):920-931. doi: 10.1002/art.40419. Epub 2018 Apr 24.

34.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

35.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

36.

Evidence-based management of Raynaud's phenomenon.

Herrick AL.

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):317-329. doi: 10.1177/1759720X17740074. Epub 2017 Nov 20. Review.

37.

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.

Denton CP, Hachulla É, Riemekasten G, Schwarting A, Frenoux JM, Frey A, Le Brun FO, Herrick AL; Raynaud Study Investigators.

Arthritis Rheumatol. 2017 Dec;69(12):2370-2379. doi: 10.1002/art.40242.

38.

Points to consider-Raynaud's phenomenon in systemic sclerosis.

Cutolo M, Smith V, Furst DE, Khanna D, Herrick AL.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v45-v48. doi: 10.1093/rheumatology/kex199. Review.

39.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE.

Scand J Rheumatol. 2018 Jan;47(1):62-70. doi: 10.1080/03009742.2017.1299793. Epub 2017 Oct 9.

PMID:
28990485
40.

ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.

Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z.

Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Review.

41.

An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).

Ingegnoli F, Ughi N, Dinsdale G, Orenti A, Boracchi P, Allanore Y, Foeldvari I, Sulli A, Cutolo M, Smith V, Herrick AL; EULAR Study Group on Microcirculation in RheumaticDiseases.

Rheumatol Int. 2017 Nov;37(11):1879-1890. doi: 10.1007/s00296-017-3808-0. Epub 2017 Sep 11.

PMID:
28894946
42.

Quartz Crystal Microbalance Assay of Clinical Calcinosis Samples and Their Synthetic Models Differentiates the Efficacy of Chelation-Based Treatments.

Fei F, Gallas A, Chang YC, Rao Y, Hunter AC, Winpenny REP, Herrick AL, Lockyer NP, Blanford CF.

ACS Appl Mater Interfaces. 2017 Aug 23;9(33):27544-27552. doi: 10.1021/acsami.7b08423. Epub 2017 Aug 15.

PMID:
28752990
43.

An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.

Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J, Shiels P, Herrick A, Worthington J, Radstake TRDJ, Martin J; Spanish Scleroderma Group.

J Rheumatol. 2017 Oct;44(10):1453-1457. doi: 10.3899/jrheum.161369. Epub 2017 Jul 1.

PMID:
28668810
44.

A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials?

Hughes M, Moore T, Manning J, Dinsdale G, Herrick AL, Murray A.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):218-219. Epub 2017 Jun 7. No abstract available.

PMID:
28598784
45.

Quantifying Digital Ulcers in Systemic Sclerosis: Reliability of Computer-Assisted Planimetry in Measuring Lesion Size.

Simpson V, Hughes M, Wilkinson J, Herrick AL, Dinsdale G.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):486-490. doi: 10.1002/acr.23300.

46.

Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy.

Dinsdale G, Moore T, O'Leary N, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Sep;113:56-59. doi: 10.1016/j.mvr.2017.05.003. Epub 2017 May 8.

PMID:
28495471
47.

Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Suliman YA, Bruni C, Johnson SR, Praino E, Alemam M, Borazan N, Cometi L, Meyers B, Khanna D, Allanore Y, Baron M, Krieg T, Herrick A, Afonso A, Distler O, Kafaja S, Denton CP, Matucci-Cerinic M, Furst DE.

J Scleroderma Relat Disord. 2017 May;2(2):115-120. doi: 10.5301/jsrd.5000236. Epub 2017 May 19.

48.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.

49.

Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy.

Dinsdale G, Moore T, O'Leary N, Tresadern P, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Jul;112:1-6. doi: 10.1016/j.mvr.2017.02.001. Epub 2017 Feb 2.

PMID:
28163035
50.

Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort.

López-Isac E, Bossini-Castillo L, Palma AB, Assassi S, Mayes MD, Simeón CP, Ortego-Centeno N, Vicente E, Tolosa C, Rubio-Rivas M, Román-Ivorra JA, Beretta L, Moroncini G, Hunzelmann N, Distler JHW, Riemekasten G, de Vries-Bouwstra J, Voskuyl AE, Radstake TRDJ, Herrick A, Denton CP, Fonseca C, Martín J.

Arthritis Rheumatol. 2017 Jun;69(6):1337-1338. doi: 10.1002/art.40058. Epub 2017 May 9. No abstract available.

Supplemental Content

Loading ...
Support Center